We are live on ! Find out more
SAM

Sectoral Asset Management Portfolio holdings

AUM $121M
1-Year Est. Return 73.47%
This Fund
S&P 500
This Quarter Est. Return
-18.58%
1 Year Est. Return
+73.47%
3 Year Est. Return
+165.77%
5 Year Est. Return
+169.27%
10 Year Est. Return
+1,136.49%
AUM
$736M
AUM Growth
-$206M
Cap. Flow
-$15M
Cap. Flow %
-2.04%
Top 10 Hldgs %
41.67%
Holding
172
New
4
Increased
40
Reduced
22
Closed
68

Top Buys

Rank Stock Value
1
TDOC icon
Teladoc Health
TDOC
+$19.6M
2
AERI
Aerie Pharmaceuticals
AERI
+$16.7M
3
GILD icon
Gilead Sciences
GILD
+$11.1M
4
IMMU
Immunomedics Inc
IMMU
+$10.5M
5
CELG
Celgene Corp
CELG
+$8.56M

Top Sells

Rank Stock Value
1
KTWO
K2M Group Holdings, Inc
KTWO
+$24.8M
2
JNJ icon
Johnson & Johnson
JNJ
+$16.9M
3
COLL icon
Collegium Pharmaceutical
COLL
+$14.2M
4
CLVS
Clovis Oncology, Inc.
CLVS
+$13M
5
ALXN
Alexion Pharmaceuticals
ALXN
+$12.3M

Sector Composition

Rank Sector Weight
1 Healthcare 81.78%
2 Technology 1.41%
3 Industrials 1.2%
4 Financials 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
OSUR icon
126
OraSure Technologies
OSUR
$273M
– –
-12,609
Closed -$195K
REGN icon
127
Regeneron Pharmaceuticals
REGN
$72.9B
– –
-1,370
Closed -$554K
RGNX icon
128
Regenxbio
RGNX
$616M
– –
-3,533
Closed -$267K
RIGL icon
129
Rigel Pharmaceuticals
RIGL
$723M
– –
-9,861
Closed -$317K
SLNO
130
DELISTED
Soleno Therapeutics
SLNO
– –
-1,439
Closed -$47K
SRPT icon
131
Sarepta Therapeutics
SRPT
$1.64B
– –
-27,000
Closed -$4.36M
STE icon
132
Steris
STE
$22.9B
– –
-2,406
Closed -$275K
TBPH icon
133
Theravance Biopharma
TBPH
$873M
– –
-7,945
Closed -$260K
TEVA icon
134
Teva Pharmaceuticals
TEVA
$40.4B
– –
-10,120
Closed -$218K
TVTX icon
135
Travere Therapeutics
TVTX
$5.17B
– –
-10,036
Closed -$288K
VTRS icon
136
Viatris
VTRS
$20.8B
– –
-14,329
Closed -$524K
WBA
137
DELISTED
Walgreens Boots Alliance
WBA
– –
-3,418
Closed -$249K
QTTB icon
138
Q32 Bio
QTTB
$435M
– –
-7,972
Closed -$3.28M
VIRX
139
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
– –
-343
Closed -$24K
GTHX
140
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
– –
-3,857
Closed -$202K
CBAY
141
DELISTED
Cymabay Therapeutics
CBAY
– –
-15,367
Closed -$170K
NVTA
142
DELISTED
Invitae Corporation
NVTA
– –
-57,144
Closed -$956K
SYNH
143
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
– –
-4,841
Closed -$250K
PRTK
144
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
– –
-12,739
Closed -$124K
NUVA
145
DELISTED
NuVasive, Inc.
NUVA
– –
-2,975
Closed -$211K
KDNY
146
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
– –
-3,784
Closed -$139K
AGRX
147
DELISTED
Agile Therapeutics
AGRX
– –
-23
Closed -$16K
CLVS
148
DELISTED
Clovis Oncology, Inc.
CLVS
– –
-443,397
Closed -$13M
HSTO
149
DELISTED
Histogen Inc. Common Stock
HSTO
– –
-52
Closed -$60K
XENT
150
DELISTED
Intersect ENT, Inc
XENT
– –
-10,226
Closed -$294K
3 4 5
6
7

Similar funds

RIP
Reliant Investment Partners Pinehurst, North Carolina $121M AUM 34.77% 1-Year Est. Return
LFWA
LiftPoint Family Wealth Advisors Far Hills, New Jersey $121M AUM
CF
Conquis Financial Milbrae, California $121M AUM 16.22% 1-Year Est. Return
WIM
Wiregrass Investment Management Thomasville, Georgia $121M AUM
MW
Merited Wealth North Bay Village, Florida $121M AUM
AFC
Avise Financial Cooperative Los Angeles, California $121M AUM
AAA
AG Asset Advisory Los Angeles, California $121M AUM 10.78% 1-Year Est. Return
TGM
Tenzing Global Management San Francisco, California $121M AUM 85.62% 1-Year Est. Return

Sectoral Asset Management's Q4 2018 Portfolio in Review

As of Q4 2018, Sectoral Asset Management held 172 positions worth $736M, down 22% from $942M the previous quarter. Its ten largest holdings account for 42% of the portfolio.

Sectoral Asset Management's Q4 2018 filing shows 4 new, 40 increased, 22 reduced and 68 closed positions. Its largest new stake was Kineta, Inc. Common Stock: 11,298 shares worth $5.13M. The largest sale was K2M Group Holdings, Inc, an estimated $24.8M.

By sector, the portfolio is most concentrated in Healthcare at 82% of assets, down from 85% a quarter earlier, followed by Technology and Industrials.

  • Sectoral Asset Management's largest Q4 2018 buy was Kineta, Inc. Common Stock: 11,298 shares worth $5.13M.
  • Sectoral Asset Management added most to Teladoc Health in Q4 2018, an estimated $19.6M increase.
  • Sectoral Asset Management's biggest Q4 2018 reduction was Johnson & Johnson, cutting an estimated $16.9M.
  • Sectoral Asset Management fully exited K2M Group Holdings, Inc in Q4 2018, selling an estimated $24.8M.
  • Sectoral Asset Management's ten largest holdings make up 42% of its $736M portfolio in Q4 2018.
  • Sectoral Asset Management opened 4 new positions and closed 68 in Q4 2018.
  • Sectoral Asset Management's portfolio value fell 22% quarter-over-quarter to $736M.

Based on Sectoral Asset Management's 13F filing for Q4 2018, filed 12 Feb 2019.